GSTO1
Glutathione S-transferase omega-1
Also known as: GSTO1_HUMAN, GSTTLp28, P28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78417
- Gene
- GSTO1
- Ensembl
- ENSG00000148834
- Chromosome
- 10
- Canonical length
- 241 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is an omega class glutathione S-transferase (GST) with glutathione-dependent thiol transferase and dehydroascorbate reductase activities. GSTs are involved in the metabolism of xenobiotics and carcinogens. The encoded protein acts as a homodimer and is found in the cytoplasm. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
241 residues, UniProt reviewed canonical sequence.
>P78417|GSTO1
1 MSGESARSLG KGSAPPGPVP EGSIRIYSMR FCPFAERTRL VLKAKGIRHE VININLKNKP
61 EWFFKKNPFG LVPVLENSQG QLIYESAITC EYLDEAYPGK KLLPDDPYEK ACQKMILELF
121 SKVPSLVGSF IRSQNKEDYA GLKEEFRKEF TKLEEVLTNK KTTFFGGNSI SMIDYLIWPW
181 FERLEAMKLN ECVDHTPKLK LWMAAMKEDP TVSALLTSEK DWQGFLELYL QNSPEACDYG
241 LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSTO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 614 nTPM
Expression across tissuesHPA
Tissue
- liver: 614 nTPM
- heart muscle: 302 nTPM
- kidney: 187 nTPM
- lung: 185 nTPM
- bone marrow: 181 nTPM
- adrenal gland: 173 nTPM
Single-cell type
- platelets: 2,523 nCPM
- megakaryocytes: 1,484 nCPM
- hepatocytes: 743 nCPM
- hofbauer cells: 491 nCPM
- cytotrophoblasts: 469 nCPM
- enterocytes: 412 nCPM
Immune cell
- basophil: 847 nTPM
- total PBMC: 632 nTPM
- classical monocyte: 534 nTPM
- intermediate monocyte: 458 nTPM
- myeloid DC: 430 nTPM
- non-classical monocyte: 371 nTPM
Brain region
- white matter: 95 nTPM
- thalamus: 86 nTPM
- midbrain: 81 nTPM
- cerebral cortex: 81 nTPM
- hypothalamus: 75 nTPM
- pons: 71 nTPM
ReferencesPubMed · IEDB
Publications for GSTO1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma.
2014 · Tumour Biol · RCR 0.9 · 26 citations - Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans.
2022 · Clin Exp Immunol · RCR 0.4 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to arsenic-containing substance
- glutathione metabolic process
- L-ascorbic acid metabolic process
- negative regulation of release of sequestered calcium ion into cytosol
- positive regulation of release of sequestered calcium ion into cytosol
- regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- xenobiotic catabolic process
- positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion
Molecular functions
- glutathione dehydrogenase (ascorbate) activity
- glutathione transferase activity
- methylarsonate reductase activity
- oxidoreductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutathione S-transferase, N-terminal
- Glutathione S-transferase, C-terminal
- Glutathione S-transferase, omega-class
- Glutathione S-transferase, C-terminal-like
- Thioredoxin-like superfamily
- Glutathione S-transferase, C-terminal domain superfamily
- Glutathione transferase family
- Glutathione S-transferase Omega/HSP26
- Glutathione S-transferase, N-terminal domain
- Glutathione S-transferase, C-terminal domain
- Glutathione S-transferase Omega/Tau-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GSTO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSTO1 as an antibody target. Whether an autoantibody or antibody against GSTO1 could matter depends on whether native GSTO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSTO1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GSTO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...